<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 13F
Form 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: September 30, 1999
Check here if Amendment [ ]; Amendment Number:
This Amendment [Check only one.]: [ ] is a restatement
[ ] adds new holdings entries
Institutional Investment Manager Filing this Report:
Name: BVF Inc.
----------------------------------
Address: 227 West Monroe Street, Suite 4800
----------------------------------
Chicago, Illinois 60606
----------------------------------
Form 13F File Number: 28-6800
-----
The institutional investment manager filing this report and the person by
whom it is signed hereby represent that the person signing the report is
authorized to submit it, that all information contained herein is true,
correct and complete, and that it is understood that all required items,
statements, schedules, lists, and tables, are considered integral parts of
this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: Mark N. Lampert
-------------------------------
Title: President
-------------------------------
Phone: (312) 263-7777
-------------------------------
Signature, Place, and Date of Signing:
/s/ Mark N. Lampert SAN FRANCISCO, CALIFORNIA 11/12/99
- ------------------------------- ------------------------- -------------
[Signature] [City, State] [Date]
Report Type (Check only one):
[ X ] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting
manager are reported in this report.)
[ ] 13F NOTICE. (Check here if no holdings reported are in this report,
and all holdings are reported by other reporting manager(s)).
<PAGE>
[ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for
this reporting manager are reported in this report and a portion are
reported by other reporting manager(s).)
Report Summary:
Number of Other Included Managers: 1
------------
Form 13F Information Table Entry Total: 37
------------
Form 13F Information Table Value Total: $185,396
------------
(thousands)
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional investment managers with respect to which this report is filed,
other than the manager filing this report.
[If there are no entries in this list, state "NONE" and omit the column headings
and list entries.]
No. Form 13F File Number Name
1. 28-6770 BVF Partners L.P.
-- ---- -----------------
<PAGE>
Page 3 of 6
<TABLE>
<CAPTION>
-----------------
FORM 13F (SEC USE ONLY)
NAME OF REPORTING MANAGER: BVF INC.
COLUMN 1: COLUMN 2: COLUMN 3: COLUMN 4: COLUMN 5: COLUMN 6: COLUMN 7: COLUMN 8:
- ------------------------------ -------------- ----------- ---------- ----------------- ---------- --------- -----------------------
VALUE SHRS SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN PRN CALL DISCRETION MANAGERS SOLE SHARED NONE
- ------------------------------ ------------ ----------- ------------ -------- --- ---- ---------- --------- -------- -------- -----
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Advanced Magnetics Inc Com 00753P103 2,841 909,235 Sh Defined 1 909,235
- -----------------------------------------------------------------------------------------------------------------------------------
Aquila Biopharm Inc Com 03839F107 598 330,126 Sh Defined 1 330,126
- -----------------------------------------------------------------------------------------------------------------------------------
Ariad Pharmaceuticals Warrant 04033A100 8 133,500 Sh Defined 1 133,500
- -----------------------------------------------------------------------------------------------------------------------------------
Arqule Inc Com 04269E107 4,130 667,500 Sh Defined 1 667,500
- -----------------------------------------------------------------------------------------------------------------------------------
Autoimmune Inc Com 052776101 769 1,366,200 Sh Defined 1 1,366,200
- -----------------------------------------------------------------------------------------------------------------------------------
Cadus Pharmaceutical Corp Com 127639102 197 900,000 Sh Defined 1 900,000
- -----------------------------------------------------------------------------------------------------------------------------------
Clinichem Dev Inc Com 186906103 1,745 225,194 Sh Defined 1 225,194
- -----------------------------------------------------------------------------------------------------------------------------------
Cortech Inc Com 22051J100 1,137 183,774 Sh Defined 1 183,774
- -----------------------------------------------------------------------------------------------------------------------------------
Corvas Intl Inc Com 221005101 8,236 2,927,743 Sh Defined 1 2,927,743
- -----------------------------------------------------------------------------------------------------------------------------------
Creative Biomolecules Inc Com 225270107 618 164,900 Sh Defined 1 164,900
- -----------------------------------------------------------------------------------------------------------------------------------
Genome Therapeutics Corp Com 372430108 6,662 1,665,585 Sh Defined 1 1,665,585
- -----------------------------------------------------------------------------------------------------------------------------------
Incyte Pharmaceuticals Inc Com 45337C102 370 16,000 Sh Defined 1 16,000
- -----------------------------------------------------------------------------------------------------------------------------------
Magainin Pharmaceuticals Inc Com 559036108 21 20,000 Sh Defined 1 20,000
- -----------------------------------------------------------------------------------------------------------------------------------
COLUMN TOTAL 27,332
- -----------------------------------------------------------------------------------------------------------------------------------
</TABLE>
<PAGE>
Page 4 of 6
<TABLE>
<CAPTION>
-----------------
FORM 13F (SEC USE ONLY)
NAME OF REPORTING MANAGER: BVF INC.
COLUMN 1: COLUMN 2: COLUMN 3: COLUMN 4: COLUMN 5: COLUMN 6: COLUMN 7: COLUMN 8:
- ------------------------------ -------------- ----------- ---------- ----------------- ---------- --------- ----------------------
VALUE SHRS SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN PRN CALL DISCRETION MANAGERS SOLE SHARED NONE
- ----------------------------- -------------- ----------- ------------ -------- --- ---- ---------- --------- -------- ------- ----
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
- -----------------------------------------------------------------------------------------------------------------------------------
Microcide Pharmaceuticals Inc Com 595018102 11,067 1,971,600 Sh Defined 1 1,971,600
- -----------------------------------------------------------------------------------------------------------------------------------
Molecular Biosystems Inc Com 608513107 183 104,700 Sh Defined 1 104,700
- -----------------------------------------------------------------------------------------------------------------------------------
Neurocrine Bioscience Inc Com 64125C109 382 68,100 Sh Defined 1 68,100
- -----------------------------------------------------------------------------------------------------------------------------------
Neurogen Corp Com 64124E106 29,742 1,789,006 Sh Defined 1 1,789,006
- -----------------------------------------------------------------------------------------------------------------------------------
NPS Pharmaceuticals Inc Com 62936P103 7,408 1,288,300 Sh Defined 1 1,288,300
- -----------------------------------------------------------------------------------------------------------------------------------
OSI Pharmaceuticals Inc Com 671040103 13,960 2,454,290 Sh Defined 1 2,454,290
- -----------------------------------------------------------------------------------------------------------------------------------
Progenics Pharmaceuticals Inc Com 743187106 15,246 781,830 Sh Defined 1 781,830
- -----------------------------------------------------------------------------------------------------------------------------------
Protein Polymer Technologies Com 743697104 163 652,000 Sh Defined 1 652,000
- -----------------------------------------------------------------------------------------------------------------------------------
QLT Phototherapeutics Inc Com 746927102 9,733 127,327 Sh Defined 1 127,327
- -----------------------------------------------------------------------------------------------------------------------------------
Repligen Corp Com 759916109 552 187,950 Sh Defined 1 187,950
- -----------------------------------------------------------------------------------------------------------------------------------
Sibia Neurosciences Inc Com 825732100 12,164 1,431,000 Sh Defined 1 1,431,000
- -----------------------------------------------------------------------------------------------------------------------------------
Sonus Pharmaceuticals Inc Com 835692104 50 15,000 Sh Defined 1 15,000
- -----------------------------------------------------------------------------------------------------------------------------------
Synaptic Pharmaceutical Corp Com 87156R109 7,087 1,417,317 Sh Defined 1 1,417,317
- -----------------------------------------------------------------------------------------------------------------------------------
COLUMN TOTAL 107,737
- -----------------------------------------------------------------------------------------------------------------------------------
</TABLE>
<PAGE>
Page 5 of 6
<TABLE>
<CAPTION>
-----------------
FORM 13F (SEC USE ONLY)
NAME OF REPORTING MANAGER: BVF INC.
COLUMN 1: COLUMN 2: COLUMN 3: COLUMN 4: COLUMN 5: COLUMN 6: COLUMN 7: COLUMN 8:
- ------------------------------ -------------- ----------- ---------- ----------------- ---------- --------- ----------------------
VALUE SHRS SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN PRN CALL DISCRETION MANAGERS SOLE SHARED NONE
- ----------------------------- -------------- ----------- ------------ -------- --- ---- ---------- --------- -------- ------- ----
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
- -----------------------------------------------------------------------------------------------------------------------------------
Titan Pharmaceuticals Inc Del Com 888314101 6,979 744,473 Sh Defined 1 744,473
- -----------------------------------------------------------------------------------------------------------------------------------
Amgen Inc Com 031162100 1,141 14,000 Sh Put Defined 1 14,000
- -----------------------------------------------------------------------------------------------------------------------------------
Biogen Inc. Com 090597105 4,335 55,000 Sh Put Defined 1 55,000
- -----------------------------------------------------------------------------------------------------------------------------------
Centocor Inc Com 152342101 8,257 14,100 Sh Put Defined 1 14,100
- -----------------------------------------------------------------------------------------------------------------------------------
Chiron Corp Com 170040109 5,538 200,000 Sh Put Defined 1 200,000
- -----------------------------------------------------------------------------------------------------------------------------------
Genzyme Corp Com 372917609 901 20,000 Sh Put Defined 1 20,000
- -----------------------------------------------------------------------------------------------------------------------------------
Gilead Sciences Inc Com 375558103 4,814 75,000 Sh Put Defined 1 75,000
- -----------------------------------------------------------------------------------------------------------------------------------
Glaxo Wellcome PLC Com 37733W105 5,616 108,000 Sh Put Defined 1 108,000
Sponsored ADR
- -----------------------------------------------------------------------------------------------------------------------------------
Johnson & Johnson Com 478160104 4,594 50,000 Sh Put Defined 1 50,000
- -----------------------------------------------------------------------------------------------------------------------------------
Merck & Co Inc Com 589331107 6,481 100,000 Sh Put Defined 1 100,000
- -----------------------------------------------------------------------------------------------------------------------------------
Smithkline Beecham PLC Com 832378301 1,671 29,000 Sh Put Defined 1 29,000
- -----------------------------------------------------------------------------------------------------------------------------------
COLUMN TOTAL 50,327
- -----------------------------------------------------------------------------------------------------------------------------------
</TABLE>
<PAGE>
Page 6 of 6
<TABLE>
<CAPTION>
-----------------
FORM 13F (SEC USE ONLY)
NAME OF REPORTING MANAGER: BVF INC.
COLUMN 1: COLUMN 2: COLUMN 3: COLUMN 4: COLUMN 5: COLUMN 6: COLUMN 7: COLUMN 8:
- ------------------------------ -------------- ----------- ---------- ----------------- ---------- --------- ----------------------
VALUE SHRS SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN PRN CALL DISCRETION MANAGERS SOLE SHARED NONE
- ----------------------------- -------------- ----------- ------------ -------- --- ---- ---------- --------- -------- ------- ----
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
</TABLE>
